Why is Ind-Swift Labs. falling/rising?

As of 02-Jul, Ind-Swift Laboratories Ltd is currently priced at 112.40, reflecting a slight increase of 0.1 (0.09%). The stock has been gaining for the last three days, with a total return of 2.28% during this period. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive short-term trend. However, there is a notable decline in investor participation, as the delivery volume has decreased by 11.76% compared to the 5-day average. While the stock has underperformed over the past year with a return of -14.30%, it has seen a significant increase in institutional investor participation, which has risen by 2.59% in the last quarter, suggesting a growing confidence among more sophisticated investors despite the company's weak long-term fundamentals.
In the broader market context, Ind-Swift Laboratories Ltd has outperformed the benchmark Sensex in the short term, with a 1-week return of +3.58% compared to the Sensex's +0.79%. However, the stock's year-to-date performance of +2.46% is lagging behind the Sensex's +6.75%. The company's recent struggles, including a significant drop in net sales and negative results over the last three quarters, contribute to its mixed performance. Despite the attractive valuation indicated by a low price-to-book ratio and a slight increase in profits, the overall sentiment remains cautious due to the company's high debt levels and declining sales, which may hinder its ability to sustain growth moving forward.